Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
CONCLUSION: Surgery of the primary tumor in patients with de novo MBC does not prolong survival, except possibly in younger/premenopausal patients. Breast surgery should be offered within the context of well-designed clinical trials examining the issue.PMID:37700450 | DOI:10.1093/oncolo/oyad266
Source: The Oncologist - Category: Cancer & Oncology Authors: Guillermo Villacampa Andri Papakonstantinou Irma Fredriksson Alexios Matikas Source Type: research
More News: Breast Cancer | Breast Surgery | Cancer | Cancer & Oncology | Clinical Trials | Conferences | Databases & Libraries | Science | Study